MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

CVS Health Corp Company Profile (NYSE:CVS)

Consensus Ratings for CVS Health Corp (NYSE:CVS) (?)
Ratings Breakdown: 3 Hold Rating(s), 19 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.91)
Consensus Price Target: $114.00 (9.72% upside)

Analysts' Ratings History for CVS Health Corp (NYSE:CVS)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016MacquarieReiterated RatingOutperform$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016FBR & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016RBC CapitalBoost Price TargetOutperform$110.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016MizuhoBoost Price TargetBuy$104.00 -> $117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016Credit SuisseInitiated CoverageOutperform$120.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016BarclaysBoost Price TargetOverweight$110.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016GuggenheimLower Price TargetBuy$120.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Goldman SachsBoost Price TargetNeutral$106.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Deutsche BankLower Price TargetHold$110.00 -> $102.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2016Leerink SwannReiterated RatingBuy$125.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Atlantic SecuritiesInitiated CoverageOverweight$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016Robert W. BairdInitiated CoverageOutperform$108.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2015Citigroup Inc.Reiterated RatingHold$105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Raymond JamesBoost Price TargetOutperform$105.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015JPMorgan Chase & Co.Lower Price TargetOverweight$128.00 -> $123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Evercore ISILower Price TargetBuy$111.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Cowen and CompanyLower Price Target$118.00 -> $113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015ArgusBoost Price TargetBuy$114.00 -> $118.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Jefferies GroupBoost Price TargetBuy$120.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Cantor FitzgeraldReiterated RatingHold$83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2015Noble FinancialReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2015StephensInitiated CoverageOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015Bank of AmericaSet Price TargetBuy$94.00 -> $104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014SunTrustUpgradeNeutral -> Buy$92.00 -> $110.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2014SusquehannaBoost Price TargetPositive$85.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2014Standpoint ResearchInitiated CoverageStrong Sell -> Sell$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/5/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha